IXC 10.5% 6.0¢ invex therapeutics ltd

Ann: Appendix 4D and Half year report, page-8

  1. 387 Posts.
    lightbulb Created with Sketch. 47
    The issue with IXC's technology is the market size. NYR's tech addresses brain injury after stroke (which has a much larger market than TBI) and can extend very easily to other indications. But I agree that IXC"s share price can turn around very quickly after a successful Phase 2 in TBI.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.007(10.5%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $3.264K 54.4K

Buyers (Bids)

No. Vol. Price($)
1 600 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.